Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider APBI in a primary breast adenoid cystic carcinoma?
Assuming the patient is otherwise a candidate for APBI.
Answer from: Radiation Oncologist at Community Practice
I would be reluctant based on local spread pattern.
Comments
Radiation Oncologist at Henry Ford Health System
Given this tumor type's high degree of local sprea...
3084
Sign in or Register to read more
7769
Related Questions
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Would you offer PMRT when the only indication is a focally positive margin?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?
What is the earliest you would start postmastectomy radiation after adjuvant chemotherapy for a patient with breast cancer?
For a young female (<40) with HR-/HER2+ cT1-2N1, ypT1aN0 s/p mastectomy with SLNB, would you offer PMRT?
What is your approach to a tumor bed boost in early stage breast cancer patients with micrometastasis?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
Is there a role for radiation therapy for florid LCIS managed with lumpectomy?
What evidence supports the use of high tangents for pN1mic breast cancer?
Given this tumor type's high degree of local sprea...